Antilipemic Drugs
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
BEZAFIBRATE: products 1 to 2 of 2.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Bezalip 400mg SR TabDIN 02083523 | General benefit | $1.7460per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Bezafibrate SR 400mg SR TabDIN 02453312 | General benefit | $1.7460per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.